APA (7th ed.) Citation

SA, M., AR, K., SW, A., MA, A., DE, J., J, M., . . . BA, W. (2020). Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate. Journal of clinical pharmacology, 60(5), 586. https://doi.org/10.1002/jcph.1558

Chicago Style (17th ed.) Citation

SA, Monk, Kugler AR, Andersen SW, Ayan-Oshodi MA, James DE, Mullen J, Zimmer JA, and Willis BA. "Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate." Journal of Clinical Pharmacology 60, no. 5 (2020): 586. https://doi.org/10.1002/jcph.1558.

MLA (9th ed.) Citation

SA, Monk, et al. "Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate." Journal of Clinical Pharmacology, vol. 60, no. 5, 2020, p. 586, https://doi.org/10.1002/jcph.1558.